Prime Editor News Today

Bollard Group LLC acquired a new position in shares of Prime Medicine, Inc. (NYSE:PRME – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 361,136 shares of the company’s stock, valued at approximately $3,200,000. Bollard Group LLC owned approximately 0.37% of Prime […]

Prime Medicine, Inc. (NYSE:PRME – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $6.50, but opened at $6.27. Prime Medicine shares last traded at $6.12, with a volume of 160,501 shares traded. Wall Street Analysts Forecast Growth Several brokerages recently commented on PRME. Chardan Capital […]

Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $6.93, but opened at $7.26. Prime Medicine shares last traded at $6.73, with a volume of 117,359 shares traded. Analysts Set New Price Targets PRME has been the topic of several […]

HC Wainwright assumed coverage on shares of Prime Medicine (NYSE:PRME – Free Report) in a report published on Monday, Marketbeat reports. The firm issued a buy rating and a $10.00 price objective on the stock. HC Wainwright also issued estimates for Prime Medicine’s Q2 2024 earnings at ($0.40) EPS, Q3 2024 earnings at ($0.40) EPS, […]

Cathie Wood splurged millions in biotech this year on strong clinical progress, AI adoption, sales growth, wider outreach, and steady product pipelines.

Levin Capital Strategies L.P. purchased a new position in Prime Medicine, Inc. (NYSE:PRME – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 20,000 shares of the company’s stock, valued at approximately $177,000. Other hedge funds have also recently modified their holdings of […]

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as $4.32 and last traded at $4.50, with a volume of 130514 shares traded. The stock had previously closed at $4.70. Wall Street Analyst Weigh In PRME has been the […]

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $6.18, but opened at $5.82. Prime Medicine shares last traded at $5.84, with a volume of 56,931 shares trading hands. Analyst Ratings Changes A number of analysts recently weighed in […]

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s stock price hit a new 52-week low on Friday . The company traded as low as $5.48 and last traded at $5.82, with a volume of 210141 shares traded. The stock had previously closed at $5.79. Wall Street Analysts Forecast Growth A number of research firms have […]

Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $6.87, but opened at $7.10. Prime Medicine shares last traded at $6.70, with a volume of 113,845 shares changing hands. Analyst Ratings Changes Several equities research analysts have recently issued […]